News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
GlaxoSmithKline Settles More Avandia Lawsuits in U.S.
June 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in a move that may defuse potentially massive claims over the medicine.
Twitter
LinkedIn
Facebook
Email
Print
Legal
GlaxoSmithKline
MORE ON THIS TOPIC
Tariffs
Trump Sets 100% Pharma Tariff Deadline for October 1
September 26, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Trump Admin Readies Proposed Rule To Lower US Drug Prices
September 26, 2025
·
2 min read
·
Tristan Manalac
Job Trends
$100,000 H-1B Fee Leaves Biopharma Grappling With Impact
September 25, 2025
·
6 min read
·
Angela Gabriel
Rare diseases
Rare Disease Experts See Futility in FDA’s Proposed Framework
September 22, 2025
·
5 min read
·
Dan Samorodnitsky